{"nct_id":"NCT03847428","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-04-29","start_date_type":"ACTUAL","primary_completion_date":"2026-05-29","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}